As of 3:59pm ET
| +0.065 / +0.14%|
Wuxi PharmaTech (Cayman), Inc. is engaged in the provision of research and development outsourcing services for the pharmaceutical, biotechnology, and medical device industries. It operates through the Laboratory Services and Manufacturing Services segments. The Laboratory Services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The Manufacturing Services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang, and Ning Zhao in 2000 and is headquartered in Shanghai, China.
|Ge Li||Chairman & Chief Executive Officer|
|Steve Yang||Chief Operating Officer & Executive Vice President|
|Edward Hu||Chief Financial & Investment Officer|
|Shu Hui Chen||Chief Scientific Officer|
|Xiao Zhong Liu||Director & Executive Vice President|